Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-09-13 Sale | 2023-09-14 4:13 pm | Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer | 8,998 | $1.3257 | $11,929 | 378,087 (Direct) | View |
| 2023-01-23 Sale | 2023-01-25 5:28 pm | Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer | 17,769 | $0.5978 | $10,622 | 324,736 (Direct) | View |
| 2022-07-19 Sale | 2022-07-20 4:05 pm | Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer | 6,013 | $1.1 | $6,614 | 172,505 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-10-10 Option Award | 2023-10-11 10:12 am | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer | 170,000 | $0 | 0 (Direct) | View |
| 2023-10-10 Disposition | 2023-10-11 10:12 am | N/A 2032-01-26 | Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer | 125,000 | $0 | 0 (Direct) | View |
| 2023-10-10 Equity Swap | 2023-10-11 10:12 am | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer | 548,087 | $0 | 0 (Direct) | View |
| 2023-09-12 Option Award | 2023-09-14 4:13 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer | 31,200 | $0 | 378,087 (Direct) | View |
| 2023-02-07 Option Award | 2023-02-09 5:11 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer | 22,547 | $0 | 355,885 (Direct) | View |
| 2023-02-08 Tax Withholding | 2023-02-09 5:11 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer | 6,544 | $0.5965 | 355,885 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 8:08 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer | 21,073 | $0 | 339,882 (Direct) | View |
| 2023-02-01 Tax Withholding | 2023-02-02 8:08 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer | 5,927 | $0.5952 | 339,882 (Direct) | View |
| 2023-01-24 Option Award | 2023-01-25 5:28 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer | 170,000 | $0 | 324,736 (Direct) | View |
| 2022-07-18 Option Award | 2022-07-20 4:05 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer | 20,800 | $0 | 172,505 (Direct) | View |
| 2022-01-26 Option Award | 2022-01-28 4:18 pm | N/A 2032-01-26 | Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer | 210,000 | $0 | 282,718 (Direct) | View |
| 2021-01-21 Option Award | 2021-01-25 4:22 pm | N/A 2031-01-21 | Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer | 130,000 | $0 | 150,718 (Direct) | View |
| 2020-01-30 Option Award | 2020-02-03 4:30 pm | N/A 2030-01-30 | Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer | 85,000 | $0 | 85,000 (Direct) | View |